Brief: Janux Therapeutics Announces First Patient Dosed With Janx007 In First-In-Human Phase 1 Clinical Trial In Patients With Prostate Cancer

Janux Therapeutics

12/10/2022 14:08

Oct 12 (Reuters) - Janux Therapeutics Inc  JANX.O :
    * JANUX THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED WITH
JANX007 IN
FIRST-IN-HUMAN PHASE 1 CLINICAL TRIAL IN PATIENTS WITH PROSTATE
CANCER

Source text for Eikon:  ID:nBw6CcHqVa 
Further company coverage:  JANX.O 
 ((Reuters.Briefs@thomsonreuters.com;))